{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:37:32Z","timestamp":1779932252441,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0902393\/99558"],"award-info":[{"award-number":["G0902393\/99558"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M015084\/1"],"award-info":[{"award-number":["MR\/M015084\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["PhD studentship"],"award-info":[{"award-number":["PhD studentship"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical guidelines and public health authorities lack recommendations on scalable approaches to defining and monitoring the occurrence and severity of bleeding in populations prescribed antithrombotic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined linked primary care, hospital admission and death registry electronic health records (CALIBER 1998\u20132010, England) of patients with newly diagnosed atrial fibrillation, acute myocardial infarction, unstable angina or stable angina with the aim to develop algorithms for bleeding events. Using the developed bleeding phenotypes, Kaplan-Meier plots were used to estimate the incidence of bleeding events and we used Cox regression models to assess the prognosis for all-cause mortality, atherothrombotic events and further bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We present electronic health record phenotyping algorithms for bleeding based on bleeding diagnosis in primary or hospital care, symptoms, transfusion, surgical procedures and haemoglobin values. In validation of the phenotype, we estimated a positive predictive value of 0.88 (95% CI 0.64, 0.99) for hospitalised bleeding. Amongst 128,815 patients, 27,259 (21.2%) had at least 1 bleeding event, with 5-year risks of bleeding of 29.1%, 21.9%, 25.3% and 23.4% following diagnoses of atrial fibrillation, acute myocardial infarction, unstable angina and stable angina, respectively. Rates of hospitalised bleeding per 1000 patients more than doubled from 1.02 (95% CI 0.83, 1.22) in January 1998 to 2.68 (95% CI 2.49, 2.88) in December 2009 coinciding with the increased rates of antiplatelet and vitamin K antagonist prescribing. Patients with hospitalised bleeding and primary care bleeding, with or without markers of severity, were at increased risk of all-cause mortality and atherothrombotic events compared to those with no bleeding. For example, the hazard ratio for all-cause mortality was 1.98 (95% CI 1.86, 2.11) for primary care bleeding with markers of severity and 1.99 (95% CI 1.92, 2.05) for hospitalised bleeding without markers of severity, compared to patients with no bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Electronic health record bleeding phenotyping algorithms offer a scalable approach to monitoring bleeding in the population. Incidence of bleeding has doubled in incidence since 1998, affects one in four cardiovascular disease patients, and is associated with poor prognosis. Efforts are required to tackle this iatrogenic epidemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-019-1438-y","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T21:01:24Z","timestamp":1574197284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Laura","family":"Pasea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Chia","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Pujades-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Alvarez-Madrazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reecha","family":"Sofat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyaz S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Timmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Denaxas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2279-0624","authenticated-orcid":false,"given":"Harry","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"issue":"7","key":"1438_CR1","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke."},{"issue":"19","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","volume":"113","author":"SC Smith Jr","year":"2006","unstructured":"Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363\u201372.","journal-title":"Circulation."},{"issue":"3","key":"1438_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"19","key":"1438_CR4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372(19):1791\u2013800.","journal-title":"N Engl J Med"},{"issue":"10","key":"1438_CR5","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016;134(10):e123\u201355.","journal-title":"Circulation"},{"key":"1438_CR6","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur J Cardiothorac Surg. 2016;50(5):e1\u2013e88."},{"issue":"5","key":"1438_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018;154(5):1121\u2013201.","journal-title":"Chest."},{"issue":"19","key":"1438_CR8","first-page":"1455","volume":"38","author":"S Halvorsen","year":"2017","unstructured":"Halvorsen S, Storey RF, Rocca B, Sibbing D, Ten Berg J, Grove EL, et al. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and\/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2017;38(19):1455\u201362.","journal-title":"Eur Heart J"},{"issue":"22","key":"1438_CR9","first-page":"1710","volume":"38","author":"A Niessner","year":"2017","unstructured":"Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, et al. Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2017;38(22):1710\u20136.","journal-title":"Eur Heart J"},{"issue":"10093","key":"1438_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","volume":"390","author":"L Li","year":"2017","unstructured":"Li L, Geraghty OC, Mehta Z, Rothwell PM. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017;390(10093):490\u20139.","journal-title":"Lancet."},{"issue":"16","key":"1438_CR11","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","volume":"170","author":"ML Hansen","year":"2010","unstructured":"Hansen ML, Sorensen R, Clausen MT, Fog-Petersen ML, Raunso J, Gadsboll N, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170(16):1433\u201341.","journal-title":"Arch Intern Med"},{"issue":"9706","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","volume":"374","author":"R Sorensen","year":"2009","unstructured":"Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet. 2009;374(9706):1967\u201374.","journal-title":"Lancet."},{"issue":"14","key":"1438_CR13","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jacc.2014.07.957","volume":"64","author":"M Hamon","year":"2014","unstructured":"Hamon M, Lemesle G, Tricot O, Meurice T, Deneve M, Dujardin X, et al. Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease. J Am Coll Cardiol. 2014;64(14):1430\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"1438_CR14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation."},{"issue":"4","key":"1438_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ahj.2006.04.012","volume":"152","author":"SD Wiviott","year":"2006","unstructured":"Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006;152(4):627\u201335.","journal-title":"Am Heart J"},{"issue":"9925","key":"1438_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(13)62070-X","volume":"383","author":"SC Chung","year":"2014","unstructured":"Chung SC, Gedeborg R, Nicholas O, James S, Jeppsson A, Wolfe C, et al. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383(9925):1305\u201312.","journal-title":"Lancet."},{"key":"1438_CR17","doi-asserted-by":"crossref","unstructured":"Rapsomaniki E, Thuresson M, Yang E, Blin P, Hunt P, Chung S-C, et al. Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 patients after myocardial infarction. Eur Heart J Qual Care Clin Outcomes. 2016;2(3):172\u201383.","DOI":"10.1093\/ehjqcco\/qcw004"},{"key":"1438_CR18","doi-asserted-by":"publisher","first-page":"f2350","DOI":"10.1136\/bmj.f2350","volume":"346","author":"E Herrett","year":"2013","unstructured":"Herrett E, Shah AD, Boggon R, Denaxas S, Smeeth L, van Staa T, et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ. 2013;346:f2350.","journal-title":"BMJ."},{"issue":"2","key":"1438_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.thromres.2005.06.015","volume":"118","author":"T Arnason","year":"2006","unstructured":"Arnason T, Wells PS, van Walraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res. 2006;118(2):253\u201362.","journal-title":"Thromb Res"},{"issue":"6","key":"1438_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/pds.2109","volume":"20","author":"A Cunningham","year":"2011","unstructured":"Cunningham A, Stein CM, Chung CP, Daugherty JR, Smalley WE, Ray WA. An automated database case definition for serious bleeding related to oral anticoagulant use. Pharmacoepidemiol Drug Saf. 2011;20(6):560\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1438_CR21","first-page":"1131","volume":"116","author":"L Friberg","year":"2016","unstructured":"Friberg L, Skeppholm M. Usefulness of health registers for detection of bleeding events in outcome studies. Thromb Haemost. 2016;116(6):1131\u20139.","journal-title":"Thromb Haemost"},{"issue":"1","key":"1438_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00001648-199601000-00018","volume":"7","author":"DS Raiford","year":"1996","unstructured":"Raiford DS, Perez Gutthann S, Garcia Rodriguez LA. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiol. 1996;7(1):101\u20134.","journal-title":"Epidemiol"},{"issue":"1","key":"1438_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/1472-6963-12-392","volume":"12","author":"CJ Crooks","year":"2012","unstructured":"Crooks CJ, Card TR, West J. Defining upper gastrointestinal bleeding from linked primary and secondary care data and the effect on occurrence and 28 day mortality. BMC Health Serv Res. 2012;12(1):392.","journal-title":"BMC Health Serv Res"},{"issue":"7217","key":"1438_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.319.7217.1106","volume":"319","author":"FJ de Abajo","year":"1999","unstructured":"de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319(7217):1106\u20139.","journal-title":"BMJ."},{"issue":"6","key":"1438_CR25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/pds.1924","volume":"19","author":"PM Wahl","year":"2010","unstructured":"Wahl PM, Rodgers K, Schneeweiss S, Gage BF, Butler J, Wilmer C, et al. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf. 2010;19(6):596\u2013603.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"1438_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jclinepi.2014.02.020","volume":"67","author":"VE Valkhoff","year":"2014","unstructured":"Valkhoff VE, Coloma PM, Masclee GM, Gini R, Innocenti F, Lapi F, et al. Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk. J Clin Epidemiol. 2014;67(8):921\u201331.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1438_CR27","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/ije\/dys188","volume":"41","author":"SC Denaxas","year":"2012","unstructured":"Denaxas SC, George J, Herrett E, Shah AD, Kalra D, Hingorani AD, et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol. 2012;41(6):1625\u201338.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"1438_CR28","doi-asserted-by":"publisher","first-page":"e110900","DOI":"10.1371\/journal.pone.0110900","volume":"9","author":"KI Morley","year":"2014","unstructured":"Morley KI, Wallace J, Denaxas SC, Hunter RJ, Patel RS, Perel P, et al. Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation. PLoS One. 2014;9(11):e110900.","journal-title":"PLoS One"},{"key":"1438_CR29","doi-asserted-by":"publisher","first-page":"i3163","DOI":"10.1136\/bmj.i3163","volume":"353","author":"A Timmis","year":"2016","unstructured":"Timmis A, Rapsomaniki E, Chung SC, Pujades-Rodriguez M, Moayyeri A, Stogiannis D, et al. Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations. BMJ. 2016;353:i3163.","journal-title":"BMJ."},{"issue":"9932","key":"1438_CR30","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899\u2013911.","journal-title":"Lancet."},{"issue":"2","key":"1438_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"AD Shah","year":"2015","unstructured":"Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105\u201313.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1438_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ije\/dyu218","volume":"44","author":"M Pujades-Rodriguez","year":"2015","unstructured":"Pujades-Rodriguez M, George J, Shah AD, Rapsomaniki E, Denaxas S, West R, et al. Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction. Int J Epidemiol. 2015;44(1):129\u201341.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"1438_CR33","doi-asserted-by":"publisher","first-page":"e104671","DOI":"10.1371\/journal.pone.0104671","volume":"9","author":"M Pujades-Rodriguez","year":"2014","unstructured":"Pujades-Rodriguez M, Timmis A, Stogiannis D, Rapsomaniki E, Denaxas S, Shah A, et al. Socioeconomic deprivation and the incidence of 12 cardiovascular diseases in 1.9 million women and men: implications for risk prediction and prevention. PloS one. 2014;9(8):e104671.","journal-title":"PloS one"},{"issue":"3","key":"1438_CR34","doi-asserted-by":"publisher","first-page":"e0151245","DOI":"10.1371\/journal.pone.0151245","volume":"11","author":"M Pujades-Rodriguez","year":"2016","unstructured":"Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Rahman A, Smeeth L, et al. Rheumatoid arthritis and incidence of twelve initial presentations of cardiovascular disease: a population record-linkage cohort study in England. PLoS One. 2016;11(3):e0151245.","journal-title":"PLoS One"},{"key":"1438_CR35","doi-asserted-by":"publisher","first-page":"j909","DOI":"10.1136\/bmj.j909","volume":"356","author":"S Bell","year":"2017","unstructured":"Bell S, Daskalopoulou M, Rapsomaniki E, George J, Britton A, Bobak M, et al. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ. 2017;356:j909.","journal-title":"BMJ."},{"issue":"9","key":"1438_CR36","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jacc.2016.12.022","volume":"69","author":"AD Shah","year":"2017","unstructured":"Shah AD, Denaxas S, Nicholas O, Hingorani AD, Hemingway H. Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER cohort study. J Am Coll Cardiol. 2017;69(9):1160\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1438_CR37","unstructured":"Gallagher AM, Puri S, Staa TV. Linkage of the General Practice Research Database (GPRD) with other data sources. Pharmacoepidemiol Drug Saf. 2011;20(S1):230\u2013364."},{"issue":"4","key":"1438_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/pubmed\/fdt116","volume":"36","author":"R Mathur","year":"2014","unstructured":"Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, vanStaa T, Grundy E, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf). 2014;36(4):684\u201392.","journal-title":"J Public Health (Oxf)"},{"issue":"3","key":"1438_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"key":"1438_CR40","unstructured":"National Institutes of Health. Electronic health records-based phenotyping 2014 [Available from: http:\/\/rethinkingclinicaltrials.org\/resources\/ehr-phenotyping\/."},{"issue":"4","key":"1438_CR41","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692\u20134.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1438_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12911-018-0623-9","volume":"18","author":"R Jackson","year":"2018","unstructured":"Jackson R, Kartoglu I, Stringer C, Gorrell G, Roberts A, Song X, et al. CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital. BMC Med Inform Decis Mak. 2018;18(1):47.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7","key":"1438_CR43","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jamacardio.2017.1460","volume":"2","author":"PO Guimaraes","year":"2017","unstructured":"Guimaraes PO, Krishnamoorthy A, Kaltenbach LA, Anstrom KJ, Effron MB, Mark DB, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary analysis of the TRANSLATE-ACS study. JAMA Cardiol. 2017;2(7):750\u20137.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"1438_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"1438_CR45","doi-asserted-by":"publisher","unstructured":"Denaxas S, Gonzalez-Izquierdo A, Direk K, Fitzpatrick NK, Fatemifar G, Banerjee A, et al. UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER. J Am Med Inform Assoc. 2019. https:\/\/doi.org\/10.1093\/jamia\/ocz105.","DOI":"10.1093\/jamia\/ocz105"},{"issue":"6","key":"1438_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1474-4422(07)70107-2","volume":"6","author":"CE Lovelock","year":"2007","unstructured":"Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6(6):487\u201393.","journal-title":"Lancet Neurol"},{"issue":"19","key":"1438_CR47","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1093\/eurheartj\/ehr340","volume":"32","author":"R Boggon","year":"2011","unstructured":"Boggon R, van Staa TP, Timmis A, Hemingway H, Ray KK, Begg A, et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. 2011;32(19):2376\u201386.","journal-title":"Eur Heart J"},{"issue":"8","key":"1438_CR48","doi-asserted-by":"publisher","first-page":"e006703","DOI":"10.1161\/JAHA.117.006703","volume":"6","author":"K Wang","year":"2017","unstructured":"Wang K, Li H, Kwong WJ, Antman EM, Ruff CT, Giugliano RP, et al. Impact of spontaneous extracranial bleeding events on health state utility in patients with atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2017;6(8):e006703.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1438_CR49","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","volume":"34","author":"EM Burns","year":"2012","unstructured":"Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, et al. Systematic review of discharge coding accuracy. J Public Health (Oxf). 2012;34(1):138\u201348.","journal-title":"J Public Health (Oxf)."},{"issue":"18","key":"1438_CR50","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.jacc.2014.01.069","volume":"63","author":"WJ Kikkert","year":"2014","unstructured":"Kikkert WJ, van Geloven N, van der Laan MH, Vis MM, Baan J Jr, Koch KT, et al. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications. J Am Coll Cardiol. 2014;63(18):1866\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1438_CR51","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ahj.2013.12.014","volume":"167","author":"EC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien EC, Holmes DN, Ansell JE, Allen LA, Hylek E, Kowey PR, et al. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2014;167(4):601\u20139 e1.","journal-title":"Am Heart J"},{"issue":"4","key":"1438_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ahj.2014.07.002","volume":"168","author":"EC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien EC, Simon DN, Allen LA, Singer DE, Fonarow GC, Kowey PR, et al. Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014;168(4):487\u201394.","journal-title":"Am Heart J"},{"issue":"14","key":"1438_CR53","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/eurheartj\/ehw683","volume":"38","author":"L Pasea","year":"2017","unstructured":"Pasea L, Chung SC, Pujades-Rodriguez M, Moayyeri A, Denaxas S, Fox KAA, et al. Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors. Eur Heart J. 2017;38(14):1048\u201355.","journal-title":"Eur Heart J"},{"issue":"5","key":"1438_CR54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.amepre.2014.11.005","volume":"48","author":"CD Williams","year":"2015","unstructured":"Williams CD, Chan AT, Elman MR, Kristensen AH, Miser WF, Pignone MP, et al. Aspirin use among adults in the U.S.: results of a national survey. Am J Prev Med. 2015;48(5):501\u20138.","journal-title":"Am J Prev Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1438-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1438-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1438-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T19:30:21Z","timestamp":1605727821000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1438-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1438-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/538249","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"11 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Anonymized primary care EHRs were obtained via the CPRD which has broad ethical approval for purely observational research using linked primary\/secondary care data for supporting medical purposes that are in the interests of patients and the wider public. Linkages with hospital EHR were performed by NHS Digital, the statutory body in England responsible for providing core healthcare information technology and curating many of the national datasets. The study was approved by the Independent Scientific Advisory Committee of the Medicines and Health care products Regulatory Agency in the UK, protocol number 14_133.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form at\n                      \n                      and declare no support from any organisation for the submitted work, no financial relationships with any organisations that might have an interest in the submitted work in the previous 3\u00a0years and no other relationships or activities that could appear to have influenced the submitted work. JTT has received research grant funding from Pfizer-BMS (manufacturer of a direct oral anticoagulant) for a completed clinical trial on atrial fibrillation in stroke. AB has been an advisory panel member for Boehringer Ingelheim and Novo Nordisk in the last 3\u2009years.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}